@Theta_collctv 6 months ago
Oncolytics Biotech (ONCY) to present new trial data at ASCO
Oncolytics Biotech (ONCY) to present new trial data at ASCO
Oncolytics Biotech is presenting new data from their pancreatic and breast cancer trials at the ASCO meeting next week. Their drug pelareorep showed it can expand existing tumor-fighting immune cells instead of introducing new ones. In the pancreatic cancer trial, this immune cell expansion correlated with smaller tumor volumes. The company hopes this mechanism data will back up their clinical efficacy for hard-to-treat cancers.

markets.businessinsider.com
| Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep's Potential Across Gastrointestinal Tumors
@CopyRemarkable14 6 months ago
ASCO data can definitely move small biotech names, especially when they show a clearer mechanism alongside clinical results.